Editas Medicine Inc (EDIT)
5.06
-0.43
(-7.83%)
USD |
NASDAQ |
Jun 14, 16:00
5.13
+0.07
(+1.38%)
After-Hours: 20:00
Editas Medicine Max Drawdown (5Y): 94.44% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 94.44% |
April 30, 2024 | 94.25% |
March 31, 2024 | 93.10% |
February 29, 2024 | 93.10% |
January 31, 2024 | 93.10% |
December 31, 2023 | 93.10% |
November 30, 2023 | 93.10% |
October 31, 2023 | 93.10% |
September 30, 2023 | 92.98% |
August 31, 2023 | 92.98% |
July 31, 2023 | 92.98% |
June 30, 2023 | 92.98% |
May 31, 2023 | 92.98% |
April 30, 2023 | 92.98% |
March 31, 2023 | 92.24% |
February 28, 2023 | 91.38% |
January 31, 2023 | 91.38% |
December 31, 2022 | 90.81% |
November 30, 2022 | 89.10% |
October 31, 2022 | 88.97% |
September 30, 2022 | 88.97% |
August 31, 2022 | 88.97% |
July 31, 2022 | 88.97% |
June 30, 2022 | 88.97% |
May 31, 2022 | 88.97% |
Date | Value |
---|---|
April 30, 2022 | 85.38% |
March 31, 2022 | 84.46% |
February 28, 2022 | 84.09% |
January 31, 2022 | 80.77% |
December 31, 2021 | 70.69% |
November 30, 2021 | 67.51% |
October 31, 2021 | 67.51% |
September 30, 2021 | 67.51% |
August 31, 2021 | 70.36% |
July 31, 2021 | 70.36% |
June 30, 2021 | 70.36% |
May 31, 2021 | 70.36% |
April 30, 2021 | 70.36% |
March 31, 2021 | 70.36% |
February 28, 2021 | 70.36% |
January 31, 2021 | 70.36% |
December 31, 2020 | 70.36% |
November 30, 2020 | 70.36% |
October 31, 2020 | 70.36% |
September 30, 2020 | 70.36% |
August 31, 2020 | 70.36% |
July 31, 2020 | 70.36% |
June 30, 2020 | 70.36% |
May 31, 2020 | 70.36% |
April 30, 2020 | 70.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
67.51%
Minimum
Sep 2021
94.44%
Maximum
May 2024
80.03%
Average
70.53%
Median
Max Drawdown (5Y) Benchmarks
Vertex Pharmaceuticals Inc | 41.60% |
Bristol-Myers Squibb Co | 47.43% |
Regeneron Pharmaceuticals Inc | 53.84% |
Cabaletta Bio Inc | -- |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -54.35 |
Beta (5Y) | 2.059 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 98.34% |
Historical Sharpe Ratio (5Y) | -0.2657 |
Historical Sortino (5Y) | -0.7525 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.67% |